SCHEMBL31708095

SCHEMBL31708095

O=C(Cl)C(=O)c1c[nH]c2c(Br)cc(F)c(OCc3ccccc3)c12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ THRA P10827 4/20 0.44
▸ THRB P10828 4/20 0.44
▸ KDM1A O60341 5/20 0.38
▸ MAOA P21397 2/20 0.38
▸ MAOB P27338 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ GLRA1 P23415 1/20 0.37
▸ DHODH Q02127 2/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MDH2 P40926 1/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ NR3C1 P04150 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ NR3C2 P08235 1/20 0.36
▸ AR P10275 1/20 0.36
▸ MRGPRX4 Q96LA9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31708099 0.90 THRA (0.42) THRATHRBKDM1AMAOAMAOB
SCHEMBL1163916 0.87 LMNA (0.40) THRATHRBNPC1DHODHFFAR4
SCHEMBL31708089 0.86 SMN1; SMN2 (0.42) THRATHRBNPC1DHODHFFAR4
SCHEMBL30712094 0.85 BRD4 (0.42) THRATHRBNPC1SMN1; SMN2HPGD
SCHEMBL31708198 0.84 THRA (0.37) THRATHRBMAOANPC1GLRA1
SCHEMBL30712065 0.83 KMT2A (0.39) THRATHRBNPC1SMN1; SMN2
SCHEMBL30712089 0.81 DPP4 (0.36) THRATHRBKDM1AMAOAMAOB
SCHEMBL1163307 0.80 THRB (0.45) THRATHRBNPC1FFAR4SMN1; SMN2
SCHEMBL4391284 0.76 LTB4R (0.37) KDM1AMAOAMAOBNPC1GLRA1
SCHEMBL30712071 0.73 PTGER1 (0.42) KDM1ANPC1SMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
Send feedback